These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 30552296)
1. Intravenously Administered Ganaxolone Blocks Diazepam-Resistant Lithium-Pilocarpine-Induced Status Epilepticus in Rats: Comparison with Allopregnanolone. Saporito MS; Gruner JA; DiCamillo A; Hinchliffe R; Barker-Haliski M; White HS J Pharmacol Exp Ther; 2019 Mar; 368(3):326-337. PubMed ID: 30552296 [TBL] [Abstract][Full Text] [Related]
2. Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus. Zolkowska D; Wu CY; Rogawski MA Epilepsia; 2018 Oct; 59 Suppl 2(Suppl 2):220-227. PubMed ID: 29453777 [TBL] [Abstract][Full Text] [Related]
3. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444 [TBL] [Abstract][Full Text] [Related]
4. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Jones DM; Esmaeil N; Maren S; Macdonald RL Epilepsy Res; 2002 Aug; 50(3):301-12. PubMed ID: 12200221 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive behavioral evaluation in the lithium-pilocarpine model in rats: effects of carisbamate administration during status epilepticus. Faure JB; Akimana G; Carneiro JE; Cosquer B; Ferrandon A; Geiger K; Koning E; Penazzi L; Cassel JC; Nehlig A Epilepsia; 2013 Jul; 54(7):1203-13. PubMed ID: 23663139 [TBL] [Abstract][Full Text] [Related]
6. Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs. Vuu I; Patterson EE; Wu CY; Zolkowska D; Leppik IE; Rogawski MA; Worrell GA; Kremen V; Cloyd JC; Coles LD J Pharmacol Exp Ther; 2022 Feb; 380(2):104-113. PubMed ID: 34862270 [TBL] [Abstract][Full Text] [Related]
7. Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Morrisett RA; Jope RS; Snead OC Exp Neurol; 1987 Jul; 97(1):193-200. PubMed ID: 3582562 [TBL] [Abstract][Full Text] [Related]
8. N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam. Rice AC; DeLorenzo RJ Neuroscience; 1999; 93(1):117-23. PubMed ID: 10430476 [TBL] [Abstract][Full Text] [Related]
9. LMR-101, a novel derivative of propofol, exhibits potent anticonvulsant effects and possibly interacts with a novel target on γ-aminobutyric acid type A receptors. Zhao Y; An L; Guo S; Huang X; Tian H; Liu L; Chen T; Sun X; Mei Q; Wang R Epilepsia; 2021 Jan; 62(1):238-249. PubMed ID: 33417274 [TBL] [Abstract][Full Text] [Related]
10. Early polytherapy for benzodiazepine-refractory status epilepticus. Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007 [TBL] [Abstract][Full Text] [Related]
11. Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects. Suchomelova L; Baldwin RA; Kubova H; Thompson KW; Sankar R; Wasterlain CG Pediatr Res; 2006 Feb; 59(2):237-43. PubMed ID: 16439585 [TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Ormandy GC; Jope RS; Snead OC Exp Neurol; 1989 Nov; 106(2):172-80. PubMed ID: 2553470 [TBL] [Abstract][Full Text] [Related]
13. Effects of transcranial focal electrical stimulation alone and associated with a sub-effective dose of diazepam on pilocarpine-induced status epilepticus and subsequent neuronal damage in rats. Besio W; Cuellar-Herrera M; Luna-Munguia H; Orozco-Suárez S; Rocha L Epilepsy Behav; 2013 Sep; 28(3):432-6. PubMed ID: 23886585 [TBL] [Abstract][Full Text] [Related]
14. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy. Reddy DS; Rogawski MA J Pharmacol Exp Ther; 2000 Sep; 294(3):909-15. PubMed ID: 10945840 [TBL] [Abstract][Full Text] [Related]
15. Treatment of late lithium-pilocarpine-induced status epilepticus with diazepam. Gao XG; Liu Y; Liu XZ Epilepsy Res; 2007 May; 74(2-3):126-30. PubMed ID: 17398071 [TBL] [Abstract][Full Text] [Related]
16. Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus. Peterson SL; Purvis RS; Griffith JW Neurotoxicology; 2004 Sep; 25(5):835-47. PubMed ID: 15288514 [TBL] [Abstract][Full Text] [Related]
17. Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers. Brandt C; Töllner K; Klee R; Bröer S; Löscher W Neurobiol Dis; 2015 Mar; 75():78-90. PubMed ID: 25549873 [TBL] [Abstract][Full Text] [Related]
18. 2-Deoxyglucose terminates pilocarpine-induced status epilepticus in neonatal rats. Janicot R; Stafstrom CE; Shao LR Epilepsia; 2020 Jul; 61(7):1528-1537. PubMed ID: 32558935 [TBL] [Abstract][Full Text] [Related]
19. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models. Löscher W Epilepsy Behav; 2015 Aug; 49():20-5. PubMed ID: 25819944 [TBL] [Abstract][Full Text] [Related]